Chilton Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13
| Closed | -$5.24K | – | 592 |
|
|
2024
Q4 | $5.24K | Buy |
+13
| New | +$5.24K | ﹤0.01% | 488 |
|
|
2022
Q1 | – | Sell |
-89
| Closed | -$20K | – | 603 |
|
|
2021
Q4 | $20K | Buy |
+89
| New | +$20K | ﹤0.01% | 420 |
|
|
2016
Q3 | – | Sell |
-31,875
| Closed | -$2.74M | – | 166 |
|
|
2016
Q2 | $2.74M | Sell |
31,875
-22,886
| -42% | -$1.97M | 0.27% | 83 |
|
|
2016
Q1 | $4.35M | Sell |
54,761
-5,419
| -9% | -$431K | 0.44% | 73 |
|
|
2015
Q4 | $7.57M | Sell |
60,180
-27,260
| -31% | -$3.43M | 0.79% | 48 |
|
|
2015
Q3 | $9.11M | Buy |
87,440
+23,966
| +38% | +$2.5M | 0.94% | 43 |
|
|
2015
Q2 | $7.84M | Sell |
63,474
-1,167
| -2% | -$144K | 0.74% | 60 |
|
|
2015
Q1 | $7.63M | Sell |
64,641
-3,788
| -6% | -$447K | 0.77% | 55 |
|
|
2014
Q4 | $8.13M | Buy |
68,429
+29,349
| +75% | +$3.49M | 0.83% | 48 |
|
|
2014
Q3 | $4.39M | Buy |
+39,080
| New | +$4.39M | 0.47% | 74 |
|